AusPAR: Omalizumab

Australian Public Assessment Report

AusPAR

AusPAR: Omalizumab [PDF, 974.92 KB]

AusPAR: Omalizumab [Word, 2.08 MB]

Attachment: Product Information for Omalizumab [PDF, 880.94 KB]

Attachment: Product Information for Omalizumab [Word, 979.7 KB]

Device/Product Name

Xolair

Active ingredients

Omalizumab

AusPAR Date

15 April 2021

Published

6 May 2021

Submission Number

PM-2019-05980-1-5

Submission Type

Extension of indication

Decision

Approved